Investigation of Pemetrexed(Alimta)cytotoxicity with non-small cell lung cancer cell lines
碩士 === 中山醫學大學 === 醫學分子毒理學研究所 === 95 === Lung cancer is the leading cause of cancer deaths worldwide . Non-small cell lung cancer (NSCLC) accounts for about 85 %, while SCLC accounts for the rest 15 %, especially the prognosis for any patient with surgery progressive remains poor. In spite of new tre...
Main Authors: | Chia-Chia, 劉佳佳 |
---|---|
Other Authors: | 許國堂 |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/78889810485026980166 |
Similar Items
-
Molecular Predictors of Response to ALIMTA in Non-Small Cell Lung Cancer
by: Yi-Fan, et al.
Published: (2012) -
Study the effect of vitamin B12 and folic acid to Pemetrexed (Alimta) efficacy with human lung cancer cells
by: Yi-Rou, et al.
Published: (2009) -
Clinical observation of Alimta monotherapy in treatment of advanced non-small cell lung cancer
by: Haiyan WANG, et al.
Published: (2008-06-01) -
Investigation of the drug resistance and migration in Alimta-resistant lung cancer cells
by: Jie-Yu, et al.
Published: (2011) -
Study the Alimta sensitivity in Docetaxel resistant lung cancer cell
by: Yu-Chen, et al.
Published: (2011)